Results

Total Results: 2,080 records

Showing results for "drug".

341. medication-assisted-treatment-protocol-160224 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-use-disorder_research-protocol.pdf
     February 24, 2016 - associated with additional risks from the high addiction potential of heroin, lack of control over drug … Food and Drug Administrated (FDA) for treatment of this condition accompanied by various psychosocial … Pharmacoepidemiol Drug Saf. Dec 2009;18(12):1166-1175. 7. Volkow ND. … America’s Addiction to Opioids: Heroin and Prescription Drug Abuse. … Prescription Drug Abuse Subcommittee.

342. Depression SSRI Surveillance Assessment_CER 62_Low-1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-treatment-ssri_surveillance.pdf
     January 01, 2013 - Food and Drug Administration (FDA), Health Canada, and UK Medicines and Healthcare products Regulatory … would produce prima facie evidence that a conclusion was out of date, such as the withdrawal of a drug … from the market, a 3 black box warning) or the availability of a new drug within class (the … Overall, there is limited supportive evidence for any single augmenting drug or for switching to a … or treat*)).tw. 39 ((treat* or therapy or drug) adj4 (resist* or fail*)).tw. 40 27 or 28 or 29

343. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1506.pdf
     November 01, 2016 - similar drugs in the same class are read separately), and then topics in the same class of a device, drug … spontaneous preterm birth, interventions intended to target both the pregnant woman and fetus (a drug … AbbVie expects to complete the pivotal trials by November 2016 and is expected to submit a new drug … If elagolix gains marketing approval, third-party payers may decline to cover the drug without data … Experts also noted that patients may prefer this oral drug over injectable alternatives.

344. chronic-fatigue-protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-fatigue_research-protocol.pdf
     May 01, 2014 - Food and Drug Administration (FDA) approved medications for the treatment of ME/CFS, but many have … Food and Drug Administration’s (FDS’s) patient-focused drug development initiative, treatments fell … Center for Drug Evaluation and Research. … Food and Drug Administration's (FDA's) Patient-Focused Drug Development Initiative. … Food and Drug Administration; 2013.

345. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/arthritis-psoriatric_research-protocol.pdf
     December 06, 2010 - Evidence-based Practice Center Systematic Review Protocol Project Title: Comparative Effectiveness of Drug … Food and Drug Administration (FDA) to treat patients with PsA are adalimumab, etanercept, golimumab, … The first review did not include certolizumab pegol, golimumab, and tocilizumab drug therapies listed … KQ3: For patients with psoriatic arthritis, do drug therapies differ in harms, tolerability, adherence … Comparative Effectiveness of Drug Therapy for Rheumatoid Arthritis and Psoriatic Arthritis in Adults

346. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - Food and Drug Administration (FDA). … Drug Enforcement Administration. … Research suggests new drug targets for depression. … Washington (DC): Drug Enforcement Administration, U.S. … Food and Drug Administration (FDA) [accessed 2013 Aug 19]. [2 p].

347. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - similar drugs in the same class are read separately), and then topics in the same class of a device, drug … Currently, the beta-amyloid antibody drug class is being investigated for treating AD. … Food and Drug administration (FDA) for the agent in late 2012. … have been used for ensuring intranasal delivery, including needle-less nostril syringes, a nasal drug … Food and Drug Administration (FDA); 2010 Dec 20. 86 p.

348. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-update_research-protocol.pdf
     May 07, 2010 - List of angiotensin converting enzyme inhibitors (ACEIs), with the U.S.Food and Drug Administration … X versus an ARB + drug X (e.g., losartan + hydrochlorothiazide [HCTZ] versus enalapril + HCTZ) … • We will exclude comparisons of an ACEI + drug X versus an ARB + drug Y (e.g., enalapril + manidipine … “ACE inhibitors” or unspecified “ARBs” vs. unspecified “ACEIs” - Include ACEI + drug X vs. … ARB + drug X (e.g., losartan + HCTZ vs. enalapril + HCTZ) - Exclude ACEI + drug X vs.

349. Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/survival-quality/research
     April 12, 2013 - In comparison to overall survival (OS), the gold standard for cancer drug evaluation, PFS can be evaluated … the primary outcome measure being used to establish the performance (efficacy and safety) of a new drug

350. Depression in Children: Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/childhood-depression/protocol
     August 24, 2018 - Reaction Reporting Systems"] or [mh Accidents] or accident*:ti,ab or [mh "Drug Toxicity"] or [mh "Drug … Allergies" OR DE "Drug Dependency" OR TX “drug effects” OR DE "Drug Sensitivity" OR TX harm* OR TX " … Reaction Reporting Systems” OR Accidents OR accident* OR “Drug Toxicity” OR “Drug Hypersensitivity” … Allergies" OR DE "Drug Dependency" OR TX “drug effects” OR DE "Drug Sensitivity" OR TX harm* OR TX " … Reaction Reporting Systems” OR Accidents OR accident* OR “Drug Toxicity” OR “Drug Hypersensitivity”

351. Medical Care Journal Supplement (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/toc.pdf
     January 01, 2007 - Designed Delays Versus Rigorous Pragmatic Trials: Lower Carat Gold Standards Can Produce Relevant Drug … Studying Prescription Drug Use and Outcomes with Medicaid Claims Data: Strengths, Limitations, and … Developing Indicators of Inpatient Adverse Drug Events Through Non-Linear Analysis Using Administrative … Evaluation and Overview of the National Electronic Injury Surveillance System- Cooperative Adverse Drug

352. Antipsychotics-Children Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
     June 04, 2010 - Food and Drug Administration (FDA). … antipsychotic drug. … All formulations of drug delivery (e.g., tablet, liquid, injectable) and doses are eligible. … dose of the same antipsychotic drug. … National Library of Medicine’s TOXLINE® and MedEffectTM Canada Adverse Drug Reaction Database.

353. Evidence-based Practice Center Systematic Review Protocol: Depression in Children: Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-childhood-protocol.pdf
     August 06, 2018 - Reaction Reporting Systems"] or [mh Accidents] or accident*:ti,ab or [mh "Drug Toxicity"] or [mh "Drug … Allergies" OR DE "Drug Dependency" OR TX “drug effects” OR DE "Drug Sensitivity" OR TX harm* OR TX … Reaction Reporting Systems” OR Accidents OR accident* OR “Drug Toxicity” OR “Drug Hypersensitivity … Allergies" OR DE "Drug Dependency" OR TX “drug effects” OR DE "Drug Sensitivity" OR TX harm* OR TX … Reaction Reporting Systems” OR Accidents OR accident* OR “Drug Toxicity” OR “Drug Hypersensitivity

354. Comparative Effectiveness of First and Second Generation Antipsychotics in the Pediatric and Young Adult Populations | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/antipsychotics-children/research-protocol
     June 04, 2010 - Food and Drug Administration (FDA). … antipsychotic drug. … All formulations of drug delivery (e.g., tablet, liquid, injectable) and doses are eligible. … antipsychotic drug, placebo, or a different dose of the same antipsychotic drug. … drug therapy.fs. randomly.ab. trial.ab. groups.ab.

355. S3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s3.pdf
     October 01, 2007 - about the occurrence and outcomes of conditions that were being targeted by therapies in the Merck drug … Beyond pharmacoepide- miology: the larger role of epidemiology in drug development. … Exposure-time-varying hazard function ratios in case-control studies of drug effects. … Pharmacoepidemiol Drug Saf. 2006;15:81–92.

356. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-adults_research-protocol.pdf
     December 01, 2010 - recommends that selection of an antipsychotic should be based on a patient’s previous responses to the drug … Study inclusion in the CER will not be limited by drug dosage. 4. … Food and Drug Administration (FDA). Comparators: Any commercially available FDA-approved SGA. … All methods of drug delivery (e.g., tablet, liquid, injection) will be eligible. … (neuroleptic adj2 (agent* or drug*)).tw. 28. or/25-27 29.

357. Fibromyalgia Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fibromyalgia_executive.pdf
     January 01, 2015 - Twenty studies were drug trials (59%). … All eight pooled analyses of patient-level RCT data were drug studies. … Corresponding and other authors in drug trials were often industry employees. … Most drug trials were placebo-controlled RCTs. … Reporting issues were particularly prominent in drug studies.

358. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
     January 01, 2012 - In 2001, teduglutide received orphan drug designation for treatment of SBS. … In August 2011, NPS began submitting data for a new drug application to FDA for the same indication … Additional, less salient considerations included potential drug-drug interactions, the possibility … The drug is also expected to be widely accepted by patients. … Food and Drug Administration (FDA); 2009 Oct 2 [accessed 2011 Feb 14]. [2 p].

359. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
     September 01, 2011 - Food and Drug Administration (FDA) recently placed a box warning on the entire class of biologic DMARDs … Health Assessment Questionnaire; CI = confidence interval; DMARD(s) = disease-modifying anti-rheumatic drug

360. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0316_03-12-2009.pdf
     January 01, 2009 - It can also be used to adjust anti-hypertensive drug therapy and reduce clinic visits with patients. … Use of anti-hypertensive drug therapy iv. BP control 3. … Use of anti-hypertensive drug therapy iv. BP control 4.